Europe — EMA
Narox (Etoricoxib)
GNH USA supplies Narox (Etoricoxib), a COX‑2 selective NSAID for osteoarthritis, rheumatoid arthritis and gout pain relief. Request a quote for global supply.
Request sourcing
What is Etoricoxib?
Etoricoxib, the active ingredient in Narox, is a COX-2 selective NSAID presented as a tablet for oral use. It treats pain and inflammation associated with osteoarthritis, rheumatoid arthritis, gout and other musculoskeletal conditions in adults.
GNH USA supplies Narox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Etoricoxib used for?
Etoricoxib is indicated for inflammatory joint disorders and acute gout flares, providing analgesic and anti‑inflammatory effects.
- Osteoarthritis: reduces joint pain and improves mobility. - Rheumatoid arthritis: decreases inflammation and slows disease‑related joint damage. - Gout: relieves acute gouty arthritis pain and swelling.
What are the side effects of Etoricoxib?
Adverse reactions may vary in frequency and severity.
Common Side Effects: - Headache: mild to moderate intensity. - Gastrointestinal discomfort: dyspepsia or abdominal pain. - Hypertension: increase in blood pressure readings. - Dizziness: transient sensation of light‑headedness.
Serious or Rare Side Effects: - Cardiovascular thrombotic events: myocardial infarction or stroke. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Gastrointestinal ulcer or bleeding: may occur without warning. - Renal impairment: acute kidney injury or worsening of chronic kidney disease. - Hepatic injury: elevated liver enzymes or hepatitis.
What precautions apply to Etoricoxib?
Before prescribing Etoricoxib, clinicians should evaluate patient‑specific risk factors and monitor therapy.
- Cardiovascular risk assessment: avoid in patients with uncontrolled hypertension or recent thrombotic events. - Blood pressure monitoring: check regularly during treatment. - Renal and hepatic function: adjust use in patients with impairment. - Hypersensitivity review: discontinue if allergic reactions develop. - Concomitant anticoagulant use: monitor for increased bleeding risk. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.
What does Etoricoxib interact with?
Etoricoxib may interact with several drug classes, requiring careful management.
Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal and cardiovascular toxicity. - CYP2C9 inhibitors (e.g., fluconazole): elevated Etoricoxib plasma levels.
Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: possible reduction in antihypertensive effect. - Lithium: risk of lithium toxicity. - Methotrexate: potential for increased methotrexate toxicity. - Antihypertensive agents: may require dose adjustment.



